FDA pharmacogenomic guidelines seen as boon to small biotechs

03/30/2005 | CNN

The FDA's recent guidelines encouraging pharmacogenomics appear to be drawing the interest of large pharmaceutical companies interested in the groundwork already begun by small biotech companies. Industry officials and analysts see the guidelines as a particular help to small companies such as Celera Genomics and deCode, two of the industry leaders in mapping the human genome and specific populations.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL